Lineage Cell Therapeutics Inc. — Director's Dealing 2021

Feb 12, 2021

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: Lineage Cell Therapeutics, Inc. (LCTX)
CIK: 0000876343
Period of Report: 2020-12-31

Reporting Person: KINGSLEY ALFRED D (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-12-01	Common Shares, no par value	G	17500	—	Disposed	5408445	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Shares, no par value	1043346	Indirect
Common Shares, no par value	375351	Indirect

Footnotes

F1: During December 2020, Mr. Kingsley gifted a total of 17,500 common shares.

F2: Held by Greenbelt Corporation, of which Mr. Kingsley is an executive officer, director, and controlling shareholder. Mr. Kingsley disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest.

F3: Held by Greenway Partners, LP, of which Mr. Kingsley is the General Partner and has sole voting and dispositive control.